Motusium and Curexo Announce Strategic Partnership to Enhance Robotic Medical Rehabilitation

December 8, 2023 2:17 AM

Austin, 10/13/2023 – Motusium, an Austin-based healthcare startup known for its pioneering solutions in rehabilitation, has embarked on an exciting new partnership with Curexo, a leader in medical robotics. This partnership will see Motusium become a key player in the U.S. expansion of Curexo's acclaimed product, Morning Walk, a gait rehabilitation robot.

Curexo, founded in 2006 and based in Seoul, South Korea, specializes in the development of medical robots, including artificial joint surgical, spine surgical, and gait rehabilitation robots. With its strong foothold in the medical robotics sector, Curexo has been a driving force in technological advancements within the medtech industry. The partnership focuses on the Morning Walk, a rehabilitation robot that stands out in Curexo's impressive lineup of medical solutions.

Motusium's collaboration with Curexo represents a significant step in broadening the accessibility of advanced rehabilitation technologies in the United States. By integrating Morning Walk into its array of rehabilitation offerings, Motusium aims to revolutionize the approach to gait rehabilitation, making cutting-edge technology readily available to patients in need of advanced recovery methods.

This partnership aligns with Motusium's commitment to utilizing AI and robotics in enhancing patient care, marking a new chapter in the company's mission to redefine rehabilitation solutions. With Curexo's Morning Walk, Motusium is set to further its impact in the U.S. healthcare market, bringing innovative solutions to the forefront of patient rehabilitation.

For more information, visit Motusium's website and Curexo's website.

About Motusium

Motusium is dedicated to transforming rehabilitation through advanced technology and patient-centered care. Their mission is to innovate in the field of rehabilitative therapy by integrating cutting-edge robotics and AI, ensuring personalized and effective treatment for patients. With a vision to redefine recovery processes, Motusium is committed to enhancing the quality of life for individuals undergoing rehabilitation, fostering faster and more efficient healing.

About Curexo

Curexo is a pioneering company in the field of medical robotics, renowned for developing innovative robotic systems for surgical and rehabilitation purposes. Their products, characterized by advanced technology and precision, are designed to enhance patient care and surgical outcomes. Curexo's portfolio includes robotic systems that are utilized in various medical fields, including orthopedics and neurosurgery, demonstrating their commitment to improving healthcare through technology.

[Contact Person]

Andrew W. Chang

CEO

Motusium

andrew.chang@motusium.com

(512) 634-3636

Disclaimer The information provided in this blog is for educational and informational purposes only and is not intended as medical advice. The content here is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health providers with any questions you may have regarding a medical condition. The views expressed on this blog are those of the individual authors and do not necessarily reflect the views of Motusium. While we strive to provide accurate and up-to-date information, Motusium makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability, or availability with respect to the blog or the information, products, services, or related graphics contained on the blog for any purpose. Any reliance you place on such information is therefore strictly at your own risk. In no event will Motusium be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this blog. Links or references to other websites or organizations do not constitute an endorsement.